1. Home
  2. BFC vs TSHA Comparison

BFC vs TSHA Comparison

Compare BFC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$145.57

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$6.83

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
TSHA
Founded
1894
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BFC
TSHA
Price
$145.57
$6.83
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$157.00
$11.63
AVG Volume (30 Days)
73.7K
2.6M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
5.56
EPS
7.23
N/A
Revenue
N/A
$9,773,000.00
Revenue This Year
$58.67
N/A
Revenue Next Year
$2.01
$1,152.42
P/E Ratio
$19.88
N/A
Revenue Growth
N/A
17.28
52 Week Low
$109.11
$1.85
52 Week High
$153.00
$6.76

Technical Indicators

Market Signals
Indicator
BFC
TSHA
Relative Strength Index (RSI) 59.68 70.56
Support Level $118.88 $4.39
Resistance Level $150.50 N/A
Average True Range (ATR) 4.97 0.40
MACD 0.13 0.03
Stochastic Oscillator 74.95 89.58

Price Performance

Historical Comparison
BFC
TSHA

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: